Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.
Also called NCT02455076
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT02455076
-
- Other papers using this trial's data
- A Randomized Controlled Trial on the Safety and Efficacy of Exenatide Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02455076. Randomized; no masking; primary purpose treatment. Start 2015-09 (actual); primary completion 2018-03 (actual). Results posted on 2019-06-20.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of Patients With Type 2 Diabetes
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- Exenatide
- Intervention (Drug)
- Glargine
- Intervention (Drug)
- Rapid-acting insulin analogs
- Lead sponsor
- Emory University
Record details
- Record id
cardio:ct-nct02455076- Content hash
839fb90ad07f03d188d2325fe288279f8eaf4f6dcbccbe1dc343b607ede7edff